Small number of Covid cases in Kerala, no need to be concerned: CM Vijayan
He said it was the Omicron JN variant LF7, which has been reported in South-East Asian countries, that has been found in Kerala.
The CM, at a press conference here, said that the total number of active Covid in the state was 727 and the majority of them were in Kottayam, Ernakulam, Thiruvananthapuram, Pathanamthitta and Alappuzha districts.
Thiruvananthapuram, May 29 (PTI) Kerala Chief Minister Pinarayi Vijayan on Thursday said a small number of Covid cases have been reported from the state, but there was no need to be concerned as testing and treatment facilities, including medicines, oxygen and ICU beds, have been ensured.
In the wake of the increase in Covid cases, the health minister had called a state-level meeting of rapid response teams and directed taking precautions and making necessary arrangements, he said.
The minister also held district-level meetings to assess the situation in the state, he added.
'Those with symptoms such as cold, sore throat, cough, and shortness of breath must wear masks. It is also advisable for the elderly, pregnant women, and those with serious illnesses to wear masks in public places and while traveling. Masks have been made mandatory in hospitals. Health workers must wear masks,' Vijayan said.
He said that the Health Department was closely monitoring the increase in Covid cases in the state.
The CM further said that since it was the rainy season, constant vigilance against infectious diseases was necessary.
He advised extreme caution against leptospirosis infection as it can be severe.
He said that those involved in relief operations or dealing with soil and sewage must take doxycycline as per the instructions of health workers to prevent leptospirosis infection.
The CM also warned against the possibility of water-borne diseases and said that only boiled water should be consumed. PTI HMP HMP KH
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
United News of India
16 minutes ago
- United News of India
Nothing to panic as COVID variant spread is of mild intensity, but Min advises pregnant women, aged to wear masks
Chennai, June 7 (UNI) Tamil Nadu Health Minister Ma Subramanian has allayed the fears of the people over the spike in COVID-19 cases stating that it was of less intensity, while advising pregnant women, the elderly people and those with co-morbidities to wear masks while moving in public places and maintain social distancing as a precautionary measure. Talking to reporters in Perundurai last evening after a convocation ceremony at Government Erode Medical College and inaugurating new buildings and laying foundation stones for new buildings, he said though no official advisory was issued on making wearing masks mandatory, it was advised that pregnant women and elderly and those with comorbidities to wear it in public places. Mr. Subramanian said that while the Union Health Ministry typically issues advisories to all the State governments during a spike in cases, no such advisory has been issued, so far in the State. Stating that the symptoms of the current Omicron variant included fever, throat pain, cold and cough, he said those with such symptoms were advised to visit the nearest government hospital for treatment. He also said the state government was all geared up tackle if there was any spike in cases by keeping ready 94,000 beds have been kept ready across the government hospitals in Tamil Nadu for treating COVID-19 patients, besides ensuring enough stock of oxygen. Tamil Nadu has so far reported little over 200 covid cases and four deaths, which were attributed to cormorbid conditions and heart problems. UNI GV 0610
Indian Express
17 minutes ago
- Indian Express
Measles spike in US shows how vaccine hesitancy threatens decades of public-health progress
Vaccines are critical tools for the containment and elimination of infectious diseases. They work not merely by protecting individuals, but by reducing community transmission. There have been several global pushes to improve vaccine uptake over the years, but one major coordinated effort occurred in 2021 in response to the Covid pandemic, which saw the most rapid vaccine introduction in history. Globally, the years with the most vaccine introductions have typically coincided with public health initiatives, funding boosts, or as a response to pandemics. The 1980s and 1990s saw WHO's Expanded Programme on Immunisation (EPI) with DTP (diphtheria-tetanus-pertussis), polio, measles, BCG (tuberculosis) vaccines and Hepatitis B and Hib vaccines introduced in the late 1990s. The 2000s saw accelerated introductions of Hepatitis B, Haemophilus influenzae type B (Hib), and yellow fever vaccines in low-income countries, marking a shift in global access to routine vaccines. The introduction of new and underused vaccines like pneumococcal conjugate vaccine (PCV), rotavirus vaccine, HPV and Measles-Rubella (MR) vaccine marked the next decade. The United States is currently experiencing a significant resurgence of measles, with 1,046 confirmed cases as of May 27. This marks a sharp increase from previous years, with the majority of cases occurring among unvaccinated individuals in regions with declining immunisation rates. Measles was officially eliminated from the US in 2000. This implies that new cases occur only when someone contracts measles abroad and returns to the country. A new study from Johns Hopkins points out that the significant drop in childhood vaccination rates is concerning because herd immunity requires at least 95 per cent vaccination coverage. The MMR vaccine is probably one of the most effective vaccines. A single dose gives 93 per cent protection from infection, and two doses up to 98 per cent. Measles, which can be deadly for unvaccinated children, is highly contagious. Factors like post-pandemic vaccine hesitancy, non-evidence-based fears of the association between the MMR vaccine and autism, and the complacency of populations who may not remember the long-term sequelae of measles infection are behind the dwindling measles vaccination rates in the US. Measles is often regarded as the 'canary in the coalmine' — if cases spread, it is a warning that other disease outbreaks might spring up where there are gaps in vaccination coverage. Its resurgence in the US is a global warning that even advanced health systems are vulnerable without consistent immunisation. Globally, only 83 per cent of children received the first dose of the measles vaccine in 2023; 74 per cent received the second dose. These figures fall short of the 95 per cent coverage needed to prevent outbreaks. India has made significant strides in its immunisation efforts, particularly under the UIP. India achieved a national immunisation coverage of 93.5 per cent in 2023–24, indicating that the majority of children received all recommended vaccines by the age of two. Since its inception, Mission Indradhanush, focused on areas with low immunisation rates, has completed 12 phases, vaccinating 5.46 crore children and 1.32 crore pregnant women across 554 districts. However, the measles upsurge in the US shows one cannot ignore increasing vaccine hesitancy, particularly since it threatens to throw away the gains made in the containment of infectious diseases. In resource-limited settings, this can lead to healthcare systems being overwhelmed and a general delay in uptake of new vaccines. Misinformation has contributed significantly to the declining uptake for vaccines. The flu vaccination rates among NHS staff in the UK, for instance, dropped to their lowest in nearly 15 years in 2024-25. So far, India has remained immune to vaccine hesitancy. Previous experience with successful vaccination campaigns and government endorsements have played an important role in creating a positive perception of vaccines. However, we must remain alert and actively consider putting in place a multi-pronged, culturally nuanced plan to address vaccine hesitancy. The writer is senior scientist, ICMR
Time of India
an hour ago
- Time of India
Gujarat now accounts for second highest number of active Covid cases
Ahmedabad/Rajkot:The state recorded 170 new Covid cases in the 24 hours ending at 5pm on Friday. Of the total, 88 were from Ahmedabad city. A total of 68 patients were declared free of infection in Gujarat, of which 34 were in Ahmedabad. In all, Gujarat has 717 active cases, according to the state health department bulletin, of which 23 are hospitalised and the rest, 694, are under home isolation. Gujarat did not record any new deaths on Friday. The health department asked patients to self-monitor health indicators and approach a medical facility if they experience respiratory issues, chest pain, or other symptoms. The bulletin also advised citizens to maintain hand hygiene, avoid spitting in public places, and ensure that those with immuno-compromised conditions wear masks and avoid crowded places. Ahmedabad city has 374 active cases, of which the West Zone has the highest number, with 128 cases, followed by 105 in the North West Zone and 66 in the South West Zone. In all, western city areas account for 80% of the city's total active cases. On Friday, the state climbed to the second spot in active cases in India at 615, after 1,679 in Kerala. Gujarat was followed by 596 in West Bengal, 592 in Delhi, and 548 in Maharashtra, among others. The dashboard of the ministry of health and family welfare (MoHFW) indicated that India recorded the deaths of four active patients in 24 hours. The patients were found to have hypertension, diabetes, cardiac issues, liver disease, urinary tract infection, and pulmonary thromboembolism as some of the comorbidities. City-based physicians said that the number of cases with flu-like symptoms is steady. Common symptoms include bodyache and headache, diarrhoea, high-grade fever, and sore throat, among others. Doctors report that common early symptoms of Covid infection include high fever, intense body aches, and headaches within the first 24 to 48 hours. Most patients are treated based on symptoms, typically presenting with flu-like signs such as cough, cold, runny nose, and sore throat. Unlike the first two waves, very few cases have involved respiratory distress. Only a small number of hospitalized patients have required oxygen support. Young children remain with their mothers and receive symptom-based care. Most patients begin to recover within 24 to 48 hours, with only a few cases becoming critical.
